BNP Paribas Financial Markets’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-182
| Closed | -$240 | – | 4673 |
|
2024
Q3 | $240 | Hold |
182
| – | – | ﹤0.01% | 3304 |
|
2024
Q2 | $1.38K | Hold |
182
| – | – | ﹤0.01% | 3164 |
|
2024
Q1 | $1.64K | Hold |
182
| – | – | ﹤0.01% | 3156 |
|
2023
Q4 | $1.95K | Hold |
182
| – | – | ﹤0.01% | 3093 |
|
2023
Q3 | $1.09K | Hold |
182
| – | – | ﹤0.01% | 3061 |
|
2023
Q2 | $1.26K | Hold |
182
| – | – | ﹤0.01% | 3128 |
|
2023
Q1 | $2.86K | Sell |
182
-41
| -18% | -$645 | ﹤0.01% | 2986 |
|
2022
Q4 | $4.46K | Hold |
223
| – | – | ﹤0.01% | 3005 |
|
2022
Q3 | $3.98K | Sell |
223
-171
| -43% | -$3.05K | ﹤0.01% | 3558 |
|
2022
Q2 | $8.74K | Sell |
394
-734
| -65% | -$16.3K | ﹤0.01% | 3121 |
|
2022
Q1 | $31.4K | Sell |
1,128
-591
| -34% | -$16.4K | ﹤0.01% | 3080 |
|
2021
Q4 | $78K | Buy |
1,719
+1,184
| +221% | +$53.7K | ﹤0.01% | 3018 |
|
2021
Q3 | $44.6K | Buy |
535
+302
| +130% | +$25.2K | ﹤0.01% | 2945 |
|
2021
Q2 | $22.1K | Buy |
+233
| New | +$22.1K | ﹤0.01% | 2914 |
|
2020
Q2 | – | Hold |
0
| – | -$12 | – | 3746 |
|
2020
Q1 | – | Hold |
0
| – | -$16 | – | 3661 |
|
2019
Q4 | – | Sell |
-5
| Closed | -$485 | – | 3711 |
|
2019
Q3 | $485 | Hold |
5
| – | – | ﹤0.01% | 3774 |
|
2019
Q2 | $646 | Sell |
5
-4
| -44% | -$517 | ﹤0.01% | 3763 |
|
2019
Q1 | $1.43K | Buy |
9
+8
| +800% | +$1.27K | ﹤0.01% | 3540 |
|
2018
Q4 | $58 | Hold |
1
| – | – | ﹤0.01% | 3562 |
|
2018
Q3 | $237 | Hold |
1
| – | – | ﹤0.01% | 3695 |
|
2018
Q2 | $2.31K | Buy |
+1
| New | +$2.31K | ﹤0.01% | 3581 |
|
2014
Q3 | – | Sell |
-2
| Closed | -$3.2K | – | 3741 |
|
2014
Q2 | $3.2K | Buy |
2
+1
| +100% | +$1.6K | ﹤0.01% | 2371 |
|
2014
Q1 | $3.15K | Sell |
1
-1
| -50% | -$3.15K | ﹤0.01% | 2101 |
|
2013
Q4 | $3.78K | Buy |
+2
| New | +$3.78K | ﹤0.01% | 2786 |
|
2013
Q3 | – | Sell |
-8
| Closed | -$75K | – | 2380 |
|
2013
Q2 | $75K | Buy |
+8
| New | +$75K | ﹤0.01% | 2267 |
|